Gut Microbiota in T2DM Patients with Microvascular Complications: A 16S rRNA Sequencing Study

Yuying Wang, Dongmei Jiang, Xia Pan, Ke Sun, Tingting Li, Xin Cao, Xiaohui Zhu Department of Endocrinology, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng City, Jiangsu Province, People’s Republic of ChinaCorrespondence: Xiaohui Zhu, Department of Endocrinolo...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Y, Jiang D, Pan X, Sun K, Li T, Cao X, Zhu X
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/gut-microbiota-in-t2dm-patients-with-microvascular-complications-a-16s-peer-reviewed-fulltext-article-DMSO
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850196094129012736
author Wang Y
Jiang D
Pan X
Sun K
Li T
Cao X
Zhu X
author_facet Wang Y
Jiang D
Pan X
Sun K
Li T
Cao X
Zhu X
author_sort Wang Y
collection DOAJ
description Yuying Wang, Dongmei Jiang, Xia Pan, Ke Sun, Tingting Li, Xin Cao, Xiaohui Zhu Department of Endocrinology, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng City, Jiangsu Province, People’s Republic of ChinaCorrespondence: Xiaohui Zhu, Department of Endocrinology, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yandu District, Yancheng City, Jiangsu Province, 224000, People’s Republic of China, Tel +86 18344764511, Email zhuxiao_hui9@163.comObjective: This study aims to investigate the characteristics of gut microbiota in patients with microvascular complications of Type 2 Diabetes Mellitus (T2DM) using 16S rRNA high-throughput sequencing technology.Methods: Patients diagnosed with T2DM were enrolled as study subjects. Based on the presence of microvascular complications, subjects were divided into a study group, a control group. Clinical fecal samples from the two groups were subjected to diversity analysis using the Illumina MiSeq high-throughput sequencing technology, comparing the richness and diversity of the gut microbiota between the two groups. The Tax4Fun software was utilized for the functional prediction of differential microbiota.Results: A total of 3727 operational taxonomic units (OTUs) were identified, with 1311 OTUs common to both groups, and 1363 and 1053 OTUs unique to the study group and the control group, respectively. The study group exhibited a significant increase in the relative abundance of Clostridia and Negativicutes, and a marked decrease in Gammaproteobacteria, Bacilli, and Verrucomicrobia compared to the control group. LefSe analysis revealed significant differences in the relative abundance at two phyla, two classes, two orders, three families, and two genera levels between the groups. KEGG pathway analysis of differential microbiota identified 10 pathways with statistically significant differences (P< 0.05).Conclusion: This study reveals significant disparities in gut microbiota abundance between T2DM patients and those with microvascular complications of T2DM, suggesting potential microbial markers for diagnosing and treating microvascular complications of T2DM.Keywords: 16S rRNA sequencing, type 2 diabetes, microvascular complications, gut microbiota
format Article
id doaj-art-45765b0b50e346b4b0df6394c6eb178f
institution OA Journals
issn 1178-7007
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj-art-45765b0b50e346b4b0df6394c6eb178f2025-08-20T02:13:32ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072025-02-01Volume 18373381100140Gut Microbiota in T2DM Patients with Microvascular Complications: A 16S rRNA Sequencing StudyWang YJiang DPan XSun KLi TCao XZhu XYuying Wang, Dongmei Jiang, Xia Pan, Ke Sun, Tingting Li, Xin Cao, Xiaohui Zhu Department of Endocrinology, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng City, Jiangsu Province, People’s Republic of ChinaCorrespondence: Xiaohui Zhu, Department of Endocrinology, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yandu District, Yancheng City, Jiangsu Province, 224000, People’s Republic of China, Tel +86 18344764511, Email zhuxiao_hui9@163.comObjective: This study aims to investigate the characteristics of gut microbiota in patients with microvascular complications of Type 2 Diabetes Mellitus (T2DM) using 16S rRNA high-throughput sequencing technology.Methods: Patients diagnosed with T2DM were enrolled as study subjects. Based on the presence of microvascular complications, subjects were divided into a study group, a control group. Clinical fecal samples from the two groups were subjected to diversity analysis using the Illumina MiSeq high-throughput sequencing technology, comparing the richness and diversity of the gut microbiota between the two groups. The Tax4Fun software was utilized for the functional prediction of differential microbiota.Results: A total of 3727 operational taxonomic units (OTUs) were identified, with 1311 OTUs common to both groups, and 1363 and 1053 OTUs unique to the study group and the control group, respectively. The study group exhibited a significant increase in the relative abundance of Clostridia and Negativicutes, and a marked decrease in Gammaproteobacteria, Bacilli, and Verrucomicrobia compared to the control group. LefSe analysis revealed significant differences in the relative abundance at two phyla, two classes, two orders, three families, and two genera levels between the groups. KEGG pathway analysis of differential microbiota identified 10 pathways with statistically significant differences (P< 0.05).Conclusion: This study reveals significant disparities in gut microbiota abundance between T2DM patients and those with microvascular complications of T2DM, suggesting potential microbial markers for diagnosing and treating microvascular complications of T2DM.Keywords: 16S rRNA sequencing, type 2 diabetes, microvascular complications, gut microbiotahttps://www.dovepress.com/gut-microbiota-in-t2dm-patients-with-microvascular-complications-a-16s-peer-reviewed-fulltext-article-DMSO16s rrna sequencingtype 2 diabetesmicrovascular complicationsgut microbiota
spellingShingle Wang Y
Jiang D
Pan X
Sun K
Li T
Cao X
Zhu X
Gut Microbiota in T2DM Patients with Microvascular Complications: A 16S rRNA Sequencing Study
Diabetes, Metabolic Syndrome and Obesity
16s rrna sequencing
type 2 diabetes
microvascular complications
gut microbiota
title Gut Microbiota in T2DM Patients with Microvascular Complications: A 16S rRNA Sequencing Study
title_full Gut Microbiota in T2DM Patients with Microvascular Complications: A 16S rRNA Sequencing Study
title_fullStr Gut Microbiota in T2DM Patients with Microvascular Complications: A 16S rRNA Sequencing Study
title_full_unstemmed Gut Microbiota in T2DM Patients with Microvascular Complications: A 16S rRNA Sequencing Study
title_short Gut Microbiota in T2DM Patients with Microvascular Complications: A 16S rRNA Sequencing Study
title_sort gut microbiota in t2dm patients with microvascular complications a 16s rrna sequencing study
topic 16s rrna sequencing
type 2 diabetes
microvascular complications
gut microbiota
url https://www.dovepress.com/gut-microbiota-in-t2dm-patients-with-microvascular-complications-a-16s-peer-reviewed-fulltext-article-DMSO
work_keys_str_mv AT wangy gutmicrobiotaint2dmpatientswithmicrovascularcomplicationsa16srrnasequencingstudy
AT jiangd gutmicrobiotaint2dmpatientswithmicrovascularcomplicationsa16srrnasequencingstudy
AT panx gutmicrobiotaint2dmpatientswithmicrovascularcomplicationsa16srrnasequencingstudy
AT sunk gutmicrobiotaint2dmpatientswithmicrovascularcomplicationsa16srrnasequencingstudy
AT lit gutmicrobiotaint2dmpatientswithmicrovascularcomplicationsa16srrnasequencingstudy
AT caox gutmicrobiotaint2dmpatientswithmicrovascularcomplicationsa16srrnasequencingstudy
AT zhux gutmicrobiotaint2dmpatientswithmicrovascularcomplicationsa16srrnasequencingstudy